Yarmouk University, also abbreviated YU is a public university, comprehensive and state supported university located near city center of Irbid in northern Jordan. Since its establishment in 1976, Yarmouk University has been at the forefront of Jordanian and Middle Eastern universities.

During the past decade, Yarmouk University conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Yarmouk University" are "Antibiotic Resistant Infection" (1 trials), "Bacterial Infections" (1 trials), "Covid19" (1 trials) and "Surgical Site Infection" (1 trials). Many other conditions were trialed in "Yarmouk University" in a lesser frequency.

Most popular intervention types in "Yarmouk University" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "ciprofloxacin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Yarmouk University" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Yarmouk University". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Yarmouk University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Yarmouk University, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".